Roche Seeks NJ High Court Review Of Accutane Expert Ruling

By Bill Wichert (August 29, 2017, 4:00 PM EDT) -- Hoffmann-La Roche Ltd. on Monday urged the New Jersey Supreme Court to review a state appellate decision reviving more than 2,000 cases alleging the company's acne medication Accutane caused patients to develop Crohn's disease, saying the court needed to clarify the appropriate degree of judicial scrutiny in evaluating expert testimony....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as